Vedolizumab as the first line of biologic therapy for ulcerative colitis and Crohn's disease – a systematic review with meta-analysis - Digestive and Liver Disease
European Crohn´s and Colitis Organisation - ECCO - P658 Evolution of disease phenotype, time to biological therapy and medium-, long-term colectomy rates in Ulcerative Colitis patients in Western Hungary – a population-based
PDF) ECCO Essential Requirements for Quality Cancer Care: Melanoma
PDF) P374 Non-alcoholic fatty liver disease in inflammatory bowel disease: Prevalence and risk factors
European Crohn´s and Colitis Organisation - ECCO - Home
EULAR 2023 – Abstract archive
European Crohn´s and Colitis Organisation - ECCO - Home
European Crohn´s and Colitis Organisation - ECCO - 14th Congress of ECCO, Copenhagen 2019
Table of Contents page: European Journal of Cancer
European Crohn´s and Colitis Organisation - ECCO - The 15th Congress of ECCO in numbers
European Crohn´s and Colitis Organisation - ECCO - 9th Congress of ECCO, Copenhagen 2014
European Crohn´s and Colitis Organisation - ECCO - Home
European Crohn´s and Colitis Organisation - ECCO - The 13th Congress of ECCO in numbers
European Crohn´s and Colitis Organisation - ECCO - Best epidemiological abstracts at ECCO'21
European Crohn´s and Colitis Organisation - ECCO - OP17 Impact of phenotypic and genetic factors on Crohn's Disease evolution in a cohort of 13,926 patients
European Crohn´s and Colitis Organisation - ECCO - Home
European Crohn´s and Colitis Organisation - ECCO - Volume 13, Issue 2
European Crohn´s and Colitis Organisation - ECCO - Statistics
Media Kit 2020 2020
European Crohn´s and Colitis Organisation - ECCO - Statistics
European Crohn´s and Colitis Organisation - ECCO - 12th Congress of ECCO, Barcelona 2017
European Crohn´s and Colitis Organisation - ECCO - Published ECCO Guidelines
Mathematics (Combinatorics) the Colombian Way: ECCO 2018
ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment
All abstracts for the ICOS Science Conference 2020 | ICOS
